Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpes Genitalis”

84 trials

Showing 20 of 84 results

Large-scale testing (Phase 3)UnknownNCT00005663
What this trial is testing

Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Who this might be right for
Herpes SimplexHIV InfectionsHerpes Genitalis
Glaxo Wellcome
Post-approval studies (Phase 4)Study completedNCT00129818
What this trial is testing

Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

Who this might be right for
Genital Herpes
Novartis
Post-approval studies (Phase 4)Study completedNCT00477334
What this trial is testing

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Who this might be right for
Genital Herpes
Novartis 463
Testing effectiveness (Phase 2)UnknownNCT03595995
What this trial is testing

Trial to Evaluate the Safety and Efficacy of UB-621

Who this might be right for
Genital Herpes
United BioPharma 80
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Not applicableStudy completedNCT01390805
What this trial is testing

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Who this might be right for
Genital Herpes
GlaxoSmithKline 462
Testing effectiveness (Phase 2)UnknownNCT04714060
What this trial is testing

UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Who this might be right for
Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd 44
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Large-scale testing (Phase 3)Study completedNCT01281007
What this trial is testing

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

Who this might be right for
GENITAL HERPES
EMS 150
Post-approval studies (Phase 4)Study completedNCT03831165
What this trial is testing

Melatonin Effects on Genital Herpes in Brazilian Women

Who this might be right for
Genital Herpes
University of Sao Paulo General Hospital 90
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Not applicableStudy completedNCT02986802
What this trial is testing

Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes

Who this might be right for
HSV-2 InfectionPreTerm BirthPregnancy Complications
Kaiser Permanente 89,132
Testing effectiveness (Phase 2)Study completedNCT02030301
What this trial is testing

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Who this might be right for
Genital Herpes Simplex Type 2
Vical 165
Not applicableStudy completedNCT04950712
What this trial is testing

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Who this might be right for
Herpes Genitalis
GlaxoSmithKline 537
Testing effectiveness (Phase 2)Study completedNCT01687595
What this trial is testing

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

Who this might be right for
Herpes Simplex Type 2
Agenus Inc. 80
Not applicableWithdrawnNCT04294030
What this trial is testing

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
HSV-2 InfectionHerpes Simplex Virus Infection
NOWDiagnostics, Inc.
Post-approval studies (Phase 4)Study completedNCT00723229
What this trial is testing

Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

Who this might be right for
Genital Herpes
University of Washington 48
Large-scale testing (Phase 3)Study completedNCT00306787
What this trial is testing

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

Who this might be right for
Genital Herpes
Novartis Pharmaceuticals 1,179
Large-scale testing (Phase 3)Study completedNCT00699764
What this trial is testing

Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease

Who this might be right for
Herpes Simplex
GlaxoSmithKline 2,491
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation